Moreover, inhibition of HMG-CoA reductase by atorvastatin was accompanied with blockages of both MYC phosphorylation and activation, suppressed tumor initiation and growth in vivo in a transgenic model of MYC-induced HCC as well as in human HCC-derived cell lines [29]. The gene discussed is HMGCR; the disease is hepatocellular carcinoma.